Skip to main content
logo
Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
15.15
-0.23 (-1.50%)
Jul 24, 2026, 4:00 PM EDT - Market closed

Q32 Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-53.74--6.653.2133.97
Revenue Growth
-----90.56%1157.25%
Gross Profit
-53.74--6.653.2133.97
Operating Income
21.4116.9-66.1-48.26-133.28-95.95
Net Income
33.2429.82-47.73-53.74-5.01-95.76
Earnings Per Share
2.662.42-6.58-153.96-6.09-31.14
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
50.7548.377.9725.62175.03155.87
Total Debt
12.9314.6518.2950.329.4823.93
Net Cash (Debt)
37.8233.6559.68-24.69145.55131.94
Net Cash Growth
-20.07%-43.62%--10.32%-34.68%
Net Cash Per Share
2.962.736.18-8.0447.3942.96

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-27.4-33.54-67.72-18.68-113.66-109.75
Capital Expenditures
---0.08-0.01-1.29-2.4
Free Cash Flow
-27.4-33.54-67.79-18.68-114.95-112.15
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%-100.00%100.00%100.00%
Operating Margin
-31.45%-725.53%-4154.64%-282.44%
Pretax Margin
-55.49%-803.26%37.34%-281.90%
Profit Margin
-55.49%-808.04%15.06%-281.90%
FCF Margin
--62.42%-280.89%-3583.10%-330.13%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
5.841.37----
PS Ratio
4.780.79--0.5722.586.12